HD-OPM Archive
Topics › Insulin resistance & diabetes

Metformin's glucose lowering is regulated by Rap1 in brain neurons, mouse study finds

Gokhan Can · Aug 03, 2025 · ♥ 15 reactions · 1 comments · original Facebook post
Insulin resistance & diabetesAging & longevity
AI summary & key facts

A Baylor College of Medicine study in Science Advances found metformin acts largely through the protein Rap1 in SF1 neurons of the hypothalamus. Mice lacking Rap1 in the brain did not respond, and a tiny dose given into the brain lowered glucose. This is preclinical mouse research.

Study Finds Metformin's Primary Glucose Lowering Action Is Regulated by the Brain

A new study from Baylor College of Medicine, published in Science Advances, has identified a novel mechanism for the diabetes drug metformin. The research indicates that metformin's primary action for lowering blood glucose is regulated by the brain, not just peripheral organs like the liver and gut as previously thought. The study found that metformin functions by inhibiting a protein called Rap1 in a specific group of neurons (SF1 neurons) located in the ventromedial hypothalamic nucleus (VMH). Experiments showed that mice genetically engineered to lack Rap1 in the brain did not respond to metformin, and that injecting a tiny, otherwise ineffective, dose of the drug directly into the brain produced significant systemic glucose-lowering effects. This discovery could pave the way for new diabetes treatments that target this brain pathway and may also shed light on metformin's reputed anti-aging properties.

Lifespan Research Institute | Building a Future Free of Age-Related DiseaseStudy Finds Metformin’s Action Is Regulated by the BrainA new study has shown that, unlike many other glucose-lowering drugs, metformin is regulated by the protein Ras1 in a specific subset of neurons.lifespan.io

Research cited

#metformin#brain#glucose#rap1#diabetes#antiaging#liver#protein
← newer: FDA approves inclisiran (Leqvio) for first-line use, with twolder: MeMeMe trial: metformin cut diabetes 80-92% in metabolic syn →